Correction to Lancet Oncol 2025: published online April 14. https://doi.org/10.1016/S1470-2045(25)00150

Abstract

Pe M, Voltz-Girolt C, Bell J, et al. Using patient-reported outcomes and health-related quality of life data in regulatory decisions on cancer treatment: highlights from an EMA-EORTC workshop. Lancet Oncol 2025; published online April 14. https://doi.org/10.1016/S1470-2045(25)00150-0—In this Essay, the affiliation of Jill Bell should have been Evinova an AstraZeneca Group, Gaithersburg, MD, USA only, and the affiliation of Jan Bogaerts should have been European Organisation for Research and Treatment of Cancer, Brussels, Belgium only. These corrections have been made to the online version as of April 30, 2025, and the printed version is correct.